Menu
Recruiting NCT05525962

Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.

Observational Behavior, Child Child Development Child Development Disorder Adolescent Development

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: questionnaries, scales, cognitive tests.
Who it may be relevant to
Registry conditions: Behavior, Child, Child Development, Child Development Disorder, Adolescent Development. Basic parameters: up to 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Facteurs de vulnérabilité/résilience influençant Les Trajectoires développementales et Les modalités Adaptatives d'Enfants et d'Adolescents confiés à l'Aide Sociale à l'Enfance. Cohorte Primo-arrivants.

Overview

Assess the prevalence of medico-psychological characteristics at the time of placement (M0), their appearance / disappearance and during the two years following placement (M12 and M24) by age group in children / adolescents in Child Protective Services and placed full-time in the structures of Seine-Maritime and Eure as well as in nursery in Le Havre or Rouen

Interventions

  • Behavioral questionnaries, scales, cognitive tests
    A first interview is planned with a psycholgist in the weeks following the minor arrival in the structure (M0) * M0: cognitive test, psychiatric classification and psychologic assessments * M12 and M24: psychiatric classification and psychologic assessments

Primary outcome measures

  • Presence and nature of psychiatric disorders according to DSM 5 [Time frame: At inclusion]
  • Presence and nature of psychiatric disorders according to DSM 5 [Time frame: 1 year after inclusion]
  • Presence and nature of psychiatric disorders according to DSM 5 [Time frame: After 2 years]
Secondary outcome measures (12)
  • Description of cognitive abilities [Time frame: At inclusion]
  • Presence of an attachement psychopathological disorder [Time frame: At inclusion]
  • Presence of a Borderline-Personality-Disorder [Time frame: At inclusion]
  • Presence of an emotional and behavioral; self-regulation Disorder [Time frame: At inclusion]
  • Presence of an emotional and behavioral; self-regulation Disorder [Time frame: At inclusion]
  • Presence of an emotional and behavioral; self-regulation Disorder [Time frame: At inclusion]
  • Presence of an emotional and behavioral; self-regulation Disorder [Time frame: At inclusion]
  • Presence of one or multisensory hallucinations [Time frame: At inclusion]
  • Mentalization capacities [Time frame: At inclusion]
  • Presence of eating disorder [Time frame: At inclusion]
  • Substance use disorders [Time frame: At inclusion]
  • Analyses of adverse life events [Time frame: At inclusion]

Eligibility criteria

Inclusion criteria

  • Minor adressed to child protective services
  • Minor placed full time

Exclusion criteria

  • Non affiliation to social security system
  • Non accompanied minor
  • Minor and/or parfents not understanding french
  • Minor informed and refused participation
  • Parents or tutor having refused participation of their child

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

France · 5 centers
  • IDEFHI — Canteleu
  • Foyer Départementale de l'Enfance — Évreux
  • Centre infantile Raymond Lerch — Le Havre
  • Centre hospitalier du Belvédère — Mont-Saint-Aignan
  • Fondation les Nids — Mont-Saint-Aignan

Identifiers

NCT: NCT05525962 · 2021/0219/HP

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗